Current Ratio of Ovid Therapeutics Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Ovid Therapeutics Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • Ovid Therapeutics Inc. Current Ratio for the quarter ending 30 Sep 2025 was 486%, a 36% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Ovid Therapeutics Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 486% -272% -36% 30 Sep 2025
Q2 2025 519% -350% -40% 30 Jun 2025
Q1 2025 545% -467% -46% 31 Mar 2025
Q4 2024 655% -488% -43% 31 Dec 2024
Q3 2024 758% -610% -45% 30 Sep 2024
Q2 2024 870% 30 Jun 2024
Q1 2024 1012% 31 Mar 2024
Q4 2023 1143% 31 Dec 2023
Q3 2023 1368% 30 Sep 2023
Q4 2021 1615% +1197% +286% 31 Dec 2021
Q3 2021 1226% +707% +137% 30 Sep 2021
Q2 2021 913% +421% +85% 30 Jun 2021
Q1 2021 629% +46% +7.9% 31 Mar 2021
Q4 2020 418% -199% -32% 31 Dec 2020
Q3 2020 518% -30% -5.5% 30 Sep 2020
Q2 2020 492% -99% -17% 30 Jun 2020
Q1 2020 582% -71% -11% 31 Mar 2020
Q4 2019 617% -104% -14% 31 Dec 2019
Q3 2019 548% -385% -41% 30 Sep 2019
Q2 2019 591% -730% -55% 30 Jun 2019
Q1 2019 653% -865% -57% 31 Mar 2019
Q4 2018 721% -783% -52% 31 Dec 2018
Q3 2018 933% -562% -38% 30 Sep 2018
Q2 2018 1321% 30 Jun 2018
Q1 2018 1518% 31 Mar 2018
Q4 2017 1504% 31 Dec 2017
Q3 2017 1495% 30 Sep 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.